VOYA Investment Management’s BioAtla BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-296
Closed -$50.9K 2833
2024
Q1
$50.9K Sell
296
-61
-17% -$7.58K ﹤0.01% 2728
2023
Q4
$43.9K Hold
357
﹤0.01% 2862
2023
Q3
$30.4K Hold
357
﹤0.01% 2888
2023
Q2
$53.6K Buy
+357
New +$61.4K ﹤0.01% 2893
2021
Q3
Sell
-96
Closed -$203K 2809
2021
Q2
$203K Hold
96
﹤0.01% 2590
2021
Q1
$244K Buy
+96
New +$246K ﹤0.01% 2426

Other funds holding BCAB

VOYA Investment Management's BCAB Position: Q2 2024 in Review

VOYA Investment Management sold out of BioAtla (BCAB) in Q2 2024, closing a stake of 296 shares — an estimated $50.9K sold.

VOYA Investment Management first reported a position in BCAB in Q1 2021 and held it in 6 quarters. The position peaked at $244K in Q1 2021. 80 funds tracked by Wall St. Rank hold BCAB as of Q2 2024.

  • VOYA Investment Management reported no remaining BioAtla position as of Q2 2024 after selling out during the quarter.
  • VOYA Investment Management sold 296 BioAtla shares in Q2 2024, an estimated $50.9K.
  • VOYA Investment Management first reported a position in BioAtla in Q1 2021 and held it in 6 quarters.
  • VOYA Investment Management's BioAtla position peaked at $244K in Q1 2021.
  • 80 funds tracked by Wall St. Rank held BioAtla as of Q2 2024.

Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.